RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yohannes Tesfaigzi to Anti-Inflammatory Agents

Back to Details
This is a "connection" page, showing publications Yohannes Tesfaigzi has written about Anti-Inflammatory Agents.
Yohannes Tesfaigzi
Connection Strength
0.368
Anti-Inflammatory Agents
  1. Smith KR, Leonard D, McDonald JD, Tesfaigzi Y. Inflammation, mucous cell metaplasia, and Bcl-2 expression in response to inhaled lipopolysaccharide aerosol and effect of rolipram. Toxicol Appl Pharmacol. 2011 Jun 15; 253(3):253-60.
    View in: PubMed
    Score: 0.338
  2. Laucho-Contreras ME, Polverino F, Tesfaigzi Y, Pilon A, Celli BR, Owen CA. Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD). Expert Opin Ther Targets. 2016 Jul; 20(7):869-83.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support